SUNNYVALE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Juki Hozumi has joined Accuray as General Manager of Japan effective November 1, 2009.
Prior to joining Accuray, Hozumi worked for Johnson & Johnson where he served as Vice President of LifeScan, Japan and General Manager of Independence Technology. Prior to joining Johnson & Johnson, Hozumi held various business leadership positions in Sales & Marketing, Business Development, Corporate Planning, and Channel Development at GE Medical Systems and Apple Japan.
"Juki Hozumi's established track record in both larger global companies where he drove rapid growth and acceptance of new product offerings, and smaller companies where he built and lead teams to grow market share, is a perfect complement to Accuray Japan," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray Incorporated. "We are very excited to have him on board and see this as a major step toward the success of our regional business model and the CyberKnife System's global expansion."
Hozumi will report to Accuray's president and chief executive officer, Euan Thomson, and will be fully responsible for leading sales, service and marketing for the Japan region.
Presently there are 21 CyberKnife Systems installed throughout Japan, making it the second largest installed base of CyberKnife Systems after the United States.
About the CyberKnife® Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 70,000 patients worldwide and currently 180 Systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.
Safe Harbor Statement
The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to qualitative management experience and commercialization of products are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2009 fiscal year, our Form 10-Q filed on November 6, 2009 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.
SOURCE Accuray Incorporated
Stephanie Tomei, Senior Manager, Marketing Communications of Accuray Incorporated, +1-408-789-4234, stomei@accuray.com; or Brianne Donahue of Schwartz Communications, +1-415-817-2545, accuray@schwartz-pr.com, for Accuray Incorporated
